Cytori Therapeutics, Inc. To Raise $13.5M In Registered Direct Offering – Benzinga
Cytori Therapeutics, Inc. To Raise $13.5M In Registered Direct OfferingBenzingaAt closing, Cytori will issue and sell to select investors 13,500 units, with each unit consisting of one share of its Series A 3.6% convertible preferred stock, which shall be convertible into the Company’s common stock (the “Conversion Shares”) and … and more …read more
Cytori Therapeutics, Inc. To Raise $13.5M In Registered Direct Offering – Benzinga Read More »